An JM - Search Results

1

Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus.

Kim HA, Nam JY, Jeon JY, An JM, Jung JY, Bae CB, Suh CH. Kim HA, et al. Among authors: an jm. J Clin Immunol. 2013 Jan;33(1):143-50. doi: 10.1007/s10875-012-9765-1. Epub 2012 Aug 23. J Clin Immunol. 2013. PMID: 22914895

2

C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.

Kim HA, Jeon JY, An JM, Koh BR, Suh CH. Kim HA, et al. Among authors: an jm. J Rheumatol. 2012 Apr;39(4):728-34. doi: 10.3899/jrheum.111044. Epub 2012 Feb 15. J Rheumatol. 2012. PMID: 22337236

3

Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.

Kim HA, An JM, Nam JY, Jeon JY, Suh CH. Kim HA, et al. Among authors: an jm. J Rheumatol. 2012 Jul;39(7):1399-406. doi: 10.3899/jrheum.120079. Epub 2012 Jun 1. J Rheumatol. 2012. PMID: 22660800

4

Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease.

Kim HA, Nam JY, Jung JY, Bae CB, An JM, Jeon JY, Kim BS, Suh CH. Kim HA, et al. Among authors: an jm. Clin Rheumatol. 2014 Jun;33(6):865-8. doi: 10.1007/s10067-014-2629-8. Epub 2014 Apr 27. Clin Rheumatol. 2014. PMID: 24770797

5

Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.

Bae CB, Suh CH, An JM, Jung JY, Jeon JY, Nam JY, Kim HA. Bae CB, et al. Among authors: an jm. J Rheumatol. 2014 Dec;41(12):2403-8. doi: 10.3899/jrheum.140651. Epub 2014 Oct 1. J Rheumatol. 2014. PMID: 25274901

6

TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.

Kim HA, Han JH, Kim WJ, Noh HJ, An JM, Yim H, Jung JY, Kim YS, Suh CH. Kim HA, et al. Among authors: an jm. Int J Mol Sci. 2016 Aug 16;17(8):1342. doi: 10.3390/ijms17081342. Int J Mol Sci. 2016. PMID: 27537874 Free PMC article.

7

3D bioprinting of engineered exosomes secreted from M2-polarized macrophages through immunomodulatory biomaterial promotes in vivo wound healing and angiogenesis.

Dutta SD, An JM, Hexiu J, Randhawa A, Ganguly K, Patil TV, Thambi T, Kim J, Lee YK, Lim KT. Dutta SD, et al. Among authors: an jm. Bioact Mater. 2024 Nov 27;45:345-362. doi: 10.1016/j.bioactmat.2024.11.026. eCollection 2025 Mar. Bioact Mater. 2024. PMID: 39669126 Free PMC article.

8

Cysteine as an Innovative Biomarker for Kidney Injury.

Woo HY, An JM, Park MY, Han A, Kim Y, Kang J, Ahn S, Min SK, Ha J, Kim D, Min S. Woo HY, et al. Among authors: an jm. Transplantation. 2024 Jul 25. doi: 10.1097/TP.0000000000005138. Online ahead of print. Transplantation. 2024. PMID: 39049125

9

Enhancing the Therapeutic Efficacy of GLP-1 for Hyperglycemia Treatment: Overcoming Barriers of Oral Gene Therapy with Taurocholic Acid-Conjugated Protamine Sulfate and Calcium Phosphate.

Shahriar SMS, An JM, Surwase SS, Lee DY, Lee YK. Shahriar SMS, et al. Among authors: an jm. ACS Nanosci Au. 2024 Apr 5;4(3):194-204. doi: 10.1021/acsnanoscienceau.3c00035. eCollection 2024 Jun 19. ACS Nanosci Au. 2024. PMID: 38912289 Free PMC article.

10

Recent advancements of hydrogels in immunotherapy: Breast cancer treatment.

Mondal J, Chakraborty K, Bunggulawa EJ, An JM, Revuri V, Nurunnabi M, Lee YK. Mondal J, et al. Among authors: an jm. J Control Release. 2024 Aug;372:1-30. doi: 10.1016/j.jconrel.2024.06.003. Epub 2024 Jun 13. J Control Release. 2024. PMID: 38849092 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters